• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

3D neuro imaging techniquerealizes Orwellian vision

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 2
Volume 31
Issue 2

University of California, San Diego scientists are developing a new imaging modality that will study the body/brain dynamics of humans engaged in normal activity.

University of California, San Diego scientists are developing a new imaging modality that will study the body/brain dynamics of humans engaged in normal activity.

The Swartz Center for Computational Neuroscience at UCSD is creating the concurrent brain and body imaging modality MoBI (Mobile Brain/Body Imaging) under a four-year $3.4 million research grant from the U.S. Navy Office of Naval Research. According to principal investigator Scott Makeig, Ph.D., the insight provided by fMRI could be used by MoBI to “read” motivations behind actions by performing cognitive monitoring. If successful, the technique will allow functional studies outside the confined laboratory setting, such as screening the brain activity of workers in stressful situations.

Recent Videos
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, Part 1
Addressing Cybersecurity Issues in Radiology
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.